SCHEMBL16556014

SCHEMBL16556014

O=C1c2cccc(F)c2CC1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.41
NOS3 P29474 1/20 0.40
NOS2 P35228 1/20 0.40
AADAT Q8N5Z0 1/20 0.39
MAPK1 P28482 1/20 0.39
SRD5A1 P18405 1/20 0.38
CYP19A1 P11511 5/20 0.38
DRD2 P14416 2/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
DRD3 P35462 1/20 0.36
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
TYMS P04818 1/20 0.34
METAP1 P53582 1/20 0.34
TYR P14679 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28725626 0.83 CYP19A1 (0.54) ACHEMAPK1CYP19A1DRD2DRD3
SCHEMBL28725627 0.83 CYP19A1 (0.54) ACHEMAPK1CYP19A1DRD2DRD3
SCHEMBL20539615 0.79 ACHE (0.40) ACHEAADATCYP19A1METAP1
SCHEMBL19764906 0.79 CDK5 (0.44) ACHECYP19A1CA1CA2CA7
SCHEMBL8556821 0.79 ACHE (0.40) ACHENOS3NOS2AADATMAPK1
SCHEMBL6472550 0.79 ACHE (0.66) ACHENOS3NOS2AADATMAPK1
SCHEMBL30666598 0.79 ACHE (0.40) ACHENOS3NOS2AADATMAPK1
SCHEMBL7335569 0.79 AADAT (0.41) ACHENOS3NOS2AADATMAPK1
SCHEMBL9317264 0.75 METAP1 (0.46) ACHENOS3NOS2AADATMAPK1
SCHEMBL14940317 0.75 CYP19A1 (0.57) ACHENOS3NOS2MAPK1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3043784-A1 ARYL ETHERS AND USES THEREOF Peloton Therapeutics, Inc. (US) 2016-07-20 EP disclosed
WO-2015035223-A1 ARYL ETHERS AND USES THEREOF PELOTON THERAPEUTICS, INC. (US) 2015-03-12 WO disclosed